# Study Evaluating the Efficacy and Safety of Miconazole Nitrate + Domiphen Bromide Vaginal Cream in the Treatment of Subjects With Acute Vulvovaginal Candidiasis

> **NCT04813822** · PHASE2 · UNKNOWN · sponsor: **Aesculape CRO Belgium BV** · enrollment: 90 (estimated)

## Conditions studied

- Acute Vulvovaginal Candidiasis

## Interventions

- **DRUG:** Miconazole Nitrate 2% + Domiphen Bromide Low Dose
- **DRUG:** Miconazole Nitrate 2% + Domiphen Bromide High Dose
- **DRUG:** Miconazole Nitrate 2%

## Key facts

- **NCT ID:** NCT04813822
- **Lead sponsor:** Aesculape CRO Belgium BV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-13
- **Primary completion:** 2022-05
- **Final completion:** 2022-10
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2022-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04813822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04813822, "Study Evaluating the Efficacy and Safety of Miconazole Nitrate + Domiphen Bromide Vaginal Cream in the Treatment of Subjects With Acute Vulvovaginal Candidiasis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04813822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*